Correction: CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

Authors Raninga, PV; Zeng, B; Moi, D; Trethowan, E; Saletta, F; Venkat, P; Mayoh, C; D'Souza, RCJ; Day, BW; Shai-Hee, T; Vittorio, O; Mazzieri, R; Dolcetti, R; Khanna, KK
Journal ONCOGENE
Pages
Volume
Date 3/04/2025
Grant ID
Funding Body
URL http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1038/s41388-025-03319-x